Increased risk of human parvovirus B19 infection in day-care employees: a cohort study among pregnant workers during an epidemic in Finland

Background Human parvovirus B19 (B19V) infection during early pregnancy increases the risk of miscarriage. Studies have inconsistently shown an elevated risk of infection among women with occupational contacts with children. Methodological differences, particularly in defining occupational exposure and in the type of reference group, may explain the conflicting findings. Methods This cohort study compared B19V infections in pregnant day-care employees and healthcare professionals during a B19V epidemic in Finland. Women were identified from the files of nationwide trade unions and the National Supervisory Authority for Welfare and Health. Early-pregnancy maternal B19V IgG was analysed in 3710 women, and infections were defined as seroconversions after analysing in parallel the available umbilical cord blood samples of the 847 seronegative mothers. Independently of the serological status, the actual employment during pregnancy was assessed using registered information on employment history. Results B19V infections were more common among day-care employees (22/331, 6.6%), than among those working in healthcare (12/326, 3.7%). The adjusted HRs of B19V infection, using proportional hazard regression, was 2.63 (95% CI 1.27 to 5.46) among all women and 5.59 (95% CI 1.40 to 22.4) among nulliparous women. Conclusions Day-care employees are at an increased risk of B19V infection, which warrants preventive measures.

[1]  E. Pattishall,et al.  Committee on Infectious Diseases , 2016, Pediatric Clinical Practice Guidelines & Policies.

[2]  B. No̸rgaard-Pedersen,et al.  Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. , 2012, American journal of epidemiology.

[3]  H. Taskinen,et al.  Pregnancy outcomes among daycare employees in Finland. , 2010, Scandinavian journal of work, environment & health.

[4]  C. Hoebe,et al.  Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  G. Enders,et al.  Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases , 2004, Prenatal diagnosis.

[6]  B. Jeune,et al.  An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors , 2000, BJOG : an international journal of obstetrics and gynaecology.

[7]  N. Crowcroft,et al.  Guidance for control of parvovirus B19 infection in healthcare settings and the community. , 1999, Journal of public health medicine.

[8]  H. Lankinen,et al.  Acute-Phase-Specific Heptapeptide Epitope for Diagnosis of Parvovirus B19 Infection , 1999, Journal of Clinical Microbiology.

[9]  P. Andersen,et al.  RISK FACTORS FOR PARVOVIRUS B19 INFECTION IN PREGNANCY , 1999 .

[10]  P. Andersen,et al.  Risk factors for parvovirus B19 infection in pregnancy. , 1999, JAMA.

[11]  B. Barnstein,et al.  Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. , 1998, The Pediatric infectious disease journal.

[12]  G. Harger,et al.  Prospective Evaluation of 618 Pregnant Women Exposed to Parvovirus B19: Risks and Symptoms , 1998, Obstetrics and gynecology.

[13]  C. Fairley,et al.  Immediate and long term outcome of human parvovirus B19 infection in pregnancy , 1998, British journal of obstetrics and gynaecology.

[14]  M Gissler,et al.  Data quality after restructuring a national medical registry. , 1995, Scandinavian journal of social medicine.

[15]  A. Best,et al.  Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. , 1993, The Journal of infectious diseases.

[16]  S. Rosengren,et al.  Occupational risk factors for infection with parvovirus B19 among pregnant women. , 1991, The Journal of infectious diseases.

[17]  M. Anderson,et al.  Prospective study of human parvovirus (B19) infection in pregnancy , 1991, BMJ.

[18]  S. Asch,et al.  Occupational Risk of Human Parvovirus B19 Infection for School and Day-Care Personnel during an Outbreak of Erythema Infectiosum , 1990 .

[19]  S. Asch,et al.  Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. , 1990, JAMA.

[20]  J. L. Montagne,et al.  Parvovirus, Erythema Infectiosum, and Pregnancy , 1990, Pediatrics.

[21]  S. Adler,et al.  Human parvovirus B19 infections in women of childbearing age and within families. , 1989, The Pediatric infectious disease journal.

[22]  N. Young,et al.  PERSISTENT B19 PARVOVIRUS INFECTION AS A CAUSE OF SEVERE CHRONIC ANAEMIA IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKAEMIA , 1988, The Lancet.

[23]  D. Reid,et al.  HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTION , 1985, The Lancet.

[24]  J. Clewley,et al.  INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALIS , 1984, The Lancet.

[25]  S. Jones,et al.  PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIA , 1981, The Lancet.

[26]  D. Goldie,et al.  CONGENITAL (FINNISH) NEPHROSIS AS CAUSE OF ABNORMAL AMNIOTIC FLUID ALPHA-FETOPROTEIN , 1981, The Lancet.

[27]  B. Cant,et al.  PARVOVIRUS-LIKE PARTICLES IN HUMAN SERA , 1975, The Lancet.

[28]  Copland Jg,et al.  SPREAD OF VIRUS HEPATITIS. , 1964 .

[29]  B. No̸rgaard-Pedersen,et al.  Parvovirus B 19 Infection in the First Trimester of Pregnancy and Risk of Fetal Loss : A Population-based Case-Control Study , 2012 .

[30]  P. Allison Survival analysis using the SAS system : a practical guide , 1995 .

[31]  M. Anderson,et al.  Experimental parvoviral infection in humans. , 1985, The Journal of infectious diseases.